In this context, while preliminary, our findings of substantially lower MT‐1E and MT‐2A expression levels among a panel of human breast cancer cell line models compared with nontransformed breast epithelial cell control suggest that such potential biomarker application may be worth pursuing further. This evidence concerns the gene MCAT and breast carcinoma.